The data indicated that PTC-209 treatment for 48 hrs led to a 40% decrease in CD44 expression in control cells, while in miR-141 IH and miR-200c IH cells the decrease in CD44 expression was only 4% and 7% respectively (Figure 10B). The gene discussed is CD44; the disease is isolated hemihyperplasia.